Quote | Panbela Therapeutics Inc Com (NASDAQ:PBLA)
Last: | $1.11 |
---|---|
Change Percent: | -10.81% |
Open: | $1.23 |
Close: | $1.11 |
High: | $1.28 |
Low: | $1.08 |
Volume: | 1,033,183 |
Last Trade Date Time: | 03/06/2024 03:00:00 am |
News | Panbela Therapeutics Inc Com (NASDAQ:PBLA)
2024-05-15 19:30:22 ET Panbela Therapeutics, Inc. (PBLA) Q1 2024 Earnings Conference Call May 15, 2024, 16:30 ET Company Participants James Carbonara - IR, HaydenIR Jennifer Simpson - President & CEO Susan Horvath - CFO Conference Call Participants ...
2024-05-15 16:20:39 ET More on Panbela Therapeutics Panbela Therapeutics, Inc. (PBLA) Q4 2023 Earnings Call Transcript Panbela Therapeutics announces delay of expected data from pancreatic cancer treatment trial Seeking Alpha’s Quant Rating on Panbela Therapeu...
Message Board Posts | Panbela Therapeutics Inc Com (NASDAQ:PBLA)
Subject | By | Source | When |
---|---|---|---|
$PBLA in the news following $7 price target: | JDCruz | investorshub | 04/28/2023 5:36:13 PM |
$PBLA Price gaining last trade up | TheFinalCD | investorshub | 04/27/2023 6:54:50 PM |
Long and strong lets hope im right | molee | investorshub | 04/27/2023 5:40:48 PM |
Oh , I can relate , as I | molee | investorshub | 04/27/2023 5:19:45 AM |
Can you imagine how the shareholders feel? IMHO | subslover | investorshub | 04/26/2023 7:06:14 PM |
News, Short Squeeze, Breakout and More Instantly...
Panbela Therapeutics Inc Com Company Name:
PBLA Stock Symbol:
NASDAQ Market:
MINNEAPOLIS, May 15, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today provides a business update and reports financial results for the q...
Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...
MINNEAPOLIS, May 06, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, today announced an Issue Notification for the US continuation patent US 11,925,613 B2 ...